相关实验视频

Updated: Jul 27, 2025

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

克服质母细胞瘤免疫疗法耐药性的障碍

Julia S Gillette¹, Elaina J Wang¹, Richard S Dowd¹

¹Departments of Neurosurgery, The Warren Alpert Medical School of Brown University, Providence, RI, United States.

Frontiers in medicine

|June 5, 2023

概括

多形质母细胞瘤 (GBM) 免疫疗法面临挑战,因为其免疫抑制瘤微环境. 组合疗法显示出克服耐药性和改善患者治疗结果的希望.

科学领域:

神经瘤学神经瘤学
免疫学免疫学免疫学
癌症生物学癌症生物学

背景情况:

多形质母细胞瘤 (GBM) 是一种具有不良预后的侵袭性原发性脑瘤.
标准治疗方法 (手术,放射,化疗) 的疗效有限.
免疫疗法在其他癌症中是成功的,但在GBM中面临重大障碍.

研究的目的:

审查GBM的内在和自适应性免疫抵抗机制.
总结目前针对GBM的工程和非工程免疫疗法.
突出有希望的组合策略,以改善GBM患者的预后.

主要方法:

关于GBM免疫疗法的临床前和临床研究的文献综述.
对GBM微环境特有的免疫抵抗因子的分析.
工程和非工程治疗方式的评估.

主要成果:

GBM表现出复杂的免疫抑制机制,阻碍T细胞功能.
组合免疫疗法在临床前和临床环境中显示出潜力.
针对多个免疫路径对于克服GBM耐药性至关重要.

结论:

了解GBM的免疫抵抗是开发有效免疫疗法的关键.
新的组合策略对于改善治疗结果至关重要.
对向免疫疗法的进一步研究可以提高患者的预后和临床护理.

关键词:

检查点抑制剂检查点抑制剂嵌合式抗原受体 (CAR) T细胞球性胃瘤 (gliobalstoma) 是一种球性胃瘤.免疫疗法免疫疗法电阻的阻力可以疫苗疫苗疫苗疫苗病毒疗法病毒疗法

更多相关视频

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma

Published on: June 2, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...